Allevion Medical Gains FDA 510(k) for Vantage System
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
Dateline: November 17, 2025 — Lisle, IllinoisHubly Surgical Inc. announced that the Auto-Stop Drill, its cordless surgical tool equipped...
LISLE, Ill., Nov. 12, 2025—Hubly Surgical announced that its Hubly Auto-Stop Drill has received FDA 510(k) clearance expanding the...
